Artificial Intelligence (AI) is already being used in advanced medical settings and it has multiple applications including, wearable technology, precision medicine and virtual clinics. In some cases, it can even interpret test results more accurately than physicians. While most of us are just beginning to realise the full potential of AI, some entrepreneurs are way ahead. But how can they build trust with investors, what are the barriers for European startups and how can smaller companies get ahead? Pascal Lardier, VP for International Events and Media Content at HIMSS moderated the session around'AI Beyond the Buzz' at the HIMSS & Health 2.0 European Digital Conference, with the panel consisting of Neha Tanna, Investment Partner, Joyance Partners, Jorge Juan Fernández García, Director of Innovation, EIT Health, and Piotr Orzechowski, Founder & CEO, Infermedica in Poland.